Streptococcus pneumoniae mAb (Cytovax)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameStreptococcus pneumoniae mAb (Cytovax)
Drug Alias NameStreptococcus pneumoniae monoclonal antibodies (Cytovax)S pneumoniae mAb (Cytovax)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytovax Biotechnologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytovax Biotechnologies
Active IndicationsN/A
Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A